Company Spotlight

Cytovance Biologics

800 Research Pkwy., Suite 200
Oklahoma City, OK 73104
United States
View Profile

Alcami

4620 Creekstone Drive
Durham, NC 27703
United States
View Profile

Adare Pharma Solutions

1200 Lenox Drive
Princeton Pike Corporate Center, Suite 100
Lawrence Township, NJ 08648
United States
View Profile


Contract Service Directory


Ambry Genetics





Company Headquarters

100 Columbia #200
Aliso Viejo, CA 92656
United States

Contract Service Directory

    Related Content

    • APIs | cGMP Manufacture | Industry News
      Cambrex Expands Capacity and Capabilites in Sweden

      Cambrex Expands Capacity and Capabilites in Sweden

      Installs new multi-purpose reactors, adds continuous flow technology at Karlskoga Facility
      05.30.17

    • Collaborations & Alliances | Drug Development
      Array, BMS in Opdivo Clinical Combo Alliance

      Array, BMS in Opdivo Clinical Combo Alliance

      To investigate Array's binimetinib in combination with BMS' Opdivo and Opdivo + Yervoy regimen in colorectal cancer
      05.30.17

    • Collaborations & Alliances | Drug Development
      Janssen Biotech, Protagonist in Exclusive PTG-200 Pact

      Janssen Biotech, Protagonist in Exclusive PTG-200 Pact

      To develop, manufacture and commercialize PTG-200 for Crohn's disease and ulcerative colitis
      05.30.17


    • Breaking News | Clinical Trial Materials | Industry News | Solid Dosage/Creams/Ointments
      Hovione Starts Phase 1 Clinical Trial of HY02

      Hovione Starts Phase 1 Clinical Trial of HY02

      HY02 is a proprietary minocycline sterile ointment to treat a subset of anterior ocular inflammation
      05.26.17

    • Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
      Avista to Support Development of an Opioid Addiction Vaccine

      Avista to Support Development of an Opioid Addiction Vaccine

      Mfg. and dev. partnership with Minneapolis Medical Research Foundation to produce conjugate vaccine to combat substance abuse
      05.26.17

    • Breaking News | Clinical Trials | Collaborations & Alliances | Toxicology

      RainDance Technologies, Ambry Genetics Enter ADME Pact

      RainDance Technologies, Inc. and Ambry Genetics have entered a collaboration focused on the development and commercialization of a comprehensive drug absorption, distribution, metabolism, and excretion (ADME) genetic screening panel.
      03.08.11